New clinical trial for treatment of COVID-19 positive patients to start at NYU Grossman School of Medicine in partnership with Montreal Heart Institute
Home > Press room > New clinical trial for treatment of COVID-19 positive patients to start at NYU Grossman School of Medicine in partnership with Montreal Heart Institute
Copied link!
Share
April 6, 2020
─
The Montreal Heart Institute Research Center today announced a strategic partnership with the NYU Grossman School of Medicine in New York City for its COVID-19 clinical study to evaluate whether colchicine will have an effect on preventing the phenomenon of major inflammatory storm present in adults suffering from severe complications related to COVID-19.
find out more by visiting the Institute’s website
Physicians with patients, or people with a positive COVID-19 diagnosis who are interested in participating in the clinical study, can call the hotline any time at 1-877-536-6837.
Press Room
September 6, 2024The 24th edition of the Bal des Grands Cœurs raised $1,401,000 for the Montreal Heart Institute Foundation
June 17, 2024A historic $140 million bequest to the benefit of our community
December 6, 2023The Right Honourable Brian Mulroney and Mrs. Mila Mulroney donate $1.5 million to support the foundations of two hospitals and a research institute